Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components

@inproceedings{Waateringe2017SkinAA,
  title={Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components},
  author={Robert P van Waateringe and Sandra N. Slagter and A P A Sandra van Beek and Melanie M. van der Klauw and Jana V van Vliet-Ostaptchouk and Reindert Graaff and Andrew D Paterson and Helen L. Lutgers and Bruce H. R. Wolffenbuttel},
  booktitle={Diabetology & metabolic syndrome},
  year={2017}
}
BACKGROUND The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased risk for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biomarker of advanced glycation end products accumulation, is associated with cardiovascular complications in subjects with diabetes. The aim of the present study was to examine the association between SAF and the presence of MetS as well as its individual components in a general… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 63 references

versal risk factors for multifactorial diseases : LifeLines : A three ‐ generation population ‐ based study

  • RP Stolk, JG Rosmalen, DS Postma, RA deBoer, G Navis, JP Slaets
  • Eur J Epidemiol
Highly Influential
5 Excerpts

Advanced glycation end‐products (AGEs) and associations with cardio‐ metabolic, lifestyle and dietary factors in a general population: the NQplus study

  • N Botros, D Sluik, RP van Waateringe, JH de Vries, A Geelen, EJ. Feskens
  • Diabetes Metab Res Rev. 2017;17:259
  • 2017
1 Excerpt

Similar Papers

Loading similar papers…